Research of 5,10-methylenetetrahydrofolate Reductase Deficiency has been linked to Hyperhomocysteinemia, Malignant Neoplasms, Cholangiocarcinoma, Thrombosis, Thrombophilia. The study of 5,10-methylenetetrahydrofolate Reductase Deficiency has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to 5,10-methylenetetrahydrofolate Reductase Deficiency include Methylation, Dna Methylation, Pathogenesis, Coagulation, Dna Repair. These pathways complement our catalog of research reagents for the study of 5,10-methylenetetrahydrofolate Reductase Deficiency including antibodies and ELISA kits against MTHFR, F2, F5, 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE, MTRR.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on 5,10-methylenetetrahydrofolate Reductase Deficiency below!
For more information on how to use Laverne, please read the How to Guide.
We have 812 products for the study of 5,10-methylenetetrahydrofolate Reductase Deficiency that can be applied to Chromatin Immunoprecipitation, Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
5,10-methylenetetrahydrofolate Reductase Deficiency is also known as Mthfr.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.